Aisling Burnand, chief executive of the biotech representative body the BIA welcomed the deal, saying she was pleased the "months …
Agreement has been reached on a new UK medicines pricing deal which safeguards the industry's ability to set its own …
Roche has been suspended from the ABPI for at least six months after being found guilty of bringing discredit on …
Over recent years the pharmaceutical industry has been unable to escape the mantra of return on investment (ROI). Investment in …
What, in your opinion, is the current state of marketing in pharma? What a question. How do you measure the …
Regulatory warning for anti-epileptic drugs presents greatest threat to non-epilepsy indicationsThe FDA is close to adding a black box warning …
Pharmaceutical marketers across Europe have a new set of rules to follow if they want to work with patient groups. …
No-one in pharmaceuticals or the NHS needs to be told their world is changing dramatically. The proof is all around, …
UK doctors have voted in favour of allowing patients to pay privately for treatments unavailable on the NHS, but continuing …
GlaxoSmithKline's Tyverb is the latest high-cost cancer treatment to be rejected by the medicines watchdog NICE. Using the breast cancer …
Lilly is to buy SGX Pharmaceuticals, a biotech company that specialises in cutting-edge technology which helps drug discovery and design. …
European pharma leaders have proposed a series of tough new measures to prevent counterfeit drugs from entering the supply chain. …
The chief executive of an innovative marine biotechnology company has been named Scottish entrepreneur of the year in healthcare. Dr …
Three pharmaceutical companies have this year been ranked inside the top 50 places to work throughout the UK. Novo Nordisk, …
As anyone working in the pharma industry knows, the industry is transforming, and fast. Four key changes are having an …
Pharmaceutical companies must adapt to changing market dynamics in 2008Pharma companies face growing competition from generics, increasingly tough pricing and …
Almirall has been Spain's number one pharmaceutical company for some years, but is still little known outside its home market. …
Shire is set to acquire German biotech firm Jerini, in a bid to expand its portfolio of treatments for rare …
A new campaign highlighting the inequality of treatment in men with prostate cancer has been launched with the help of …